1. States during the 20th century: Trends in infectious disease martality in the United States;Armstrong;Journal of the American Medical Association,1999
2. Chapter II, The course, symptoms and physical findings;Bullowa,1937
3. Cubist Pharmaceuticals (n.d.) Recent results and 2010 plans. http://www.cubist.com/investor_relations (accessed November 2010).
4. Research and development costs and returns by therapeutic category;DiMasi;Drug Information Journal,2004
5. Antimicrobial pharmacodynamics: Critical interactions of ‘bug and drug’;Drusano;Nature Reviews Microbiology,2004